[1] Geng H, Xing Y, Zhang J, Cao K, Ye M, Wang G, Liu C. Association between viral infection other than human papillomavirus and risk of esophageal carcinoma:a comprehensive meta-analysis of epidemiological studies[J]. Arch Virol, 2022, 167:1-20. [2] Xu M, Yao Y, Chen H, Zhang S, Cao SM, Zhang Z, Luo B, Liu Z, Li Z, Xiang T, He G, Feng QS, Chen LZ, Guo X, Jia WH, Chen MY, Zhang X, Xie SH, Peng R, Chang ET, Pedergnana V, Feng L, Bei JX, Xu RH, Zeng MS, Ye W, Adami HO, Lin X, Zhai W, Zeng YX, Liu J. Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinoma[J]. Nat Genet, 2019, 51:1131-1136. [3] Lei J, Ploner A, Elfström KM, Wang J, Roth A, Fang F, Sundström K, Dillner J, Sparén P. HPV vaccination and the risk of invasive cervical cancer[J]. N Engl J Med, 2020, 383:1340-1348. [4] Liu HY, Yu XG, Chen L. Oncolytic viruses for the treatment of malignant glioma[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2020, 20:111-118.[刘鸿宇, 余新光, 陈凌. 恶性胶质瘤溶瘤病毒治疗进展[J]. 中国现代神经疾病杂志, 2020, 20:111-118.] [5] Qian ZY, Wu YY, Huang Q, Zhai DZ, Zhu Q, Wang AD, Huo HM, Lan Q. Expression of SV40Tag, Rb and IRS-1 in glioma detected by tissue microarray and their relation with tumorigenesis and progression of gliomas[J]. Zhonghua Zhong Liu Za Zhi, 2008, 30:432-436.[钱志远, 吴银艳, 黄强, 翟德忠,朱卿, 王爱东, 霍红梅, 兰青. 胶质瘤组织中SV40Tag Rb和IRS-1蛋白的表达及其与胶质瘤发生发展的关系[J]. 中华肿瘤杂志, 2008, 30:432-436.] [6] Wen KW, Wang L, Menke JR, Damania B. Cancers associated with human gammaherpesviruses[J]. FEBS J, 2021.[Epub ahead of print] [7] Wang HY, Valencia SM, Pfeifer SP, Jensen JD, Kowalik TF, Permar SR. Common polymorphisms in the glycoproteins of human cytomegalovirus and associated strain-specific immunity[J]. Viruses, 2021, 13:1106. [8] Fulkerson HL, Nogalski MT, Collins-McMillen D, Yurochko AD. Overview of human cytomegalovirus pathogenesis[J]. Methods Mol Biol, 2021, 2244:1-18. [9] Kennedy PGE. An overview of viral infections of the nervous system in the immunosuppressed[J]. J Neurol, 2021, 268:3026-3030. [10] Shan YL, Zhang SH, Chen WH, Jiang PX, Chen JL. Research of latent infection and active infection of human cytomegalovirus[J]. Xian Dai Sheng Wu Yi Xue Jin Zhan, 2011, 11:3382-3385.[单幼兰, 张笋华, 陈伟华, 江培学, 陈家梁. 关于HCMV潜伏感染与激活感染研究的新进展[J]. 现代生物医学进展, 2011, 11:3382-3385.] [11] Zou HM, Huang ZF, Yang Y, Luo WW, Wang SY, Luo MH, Fu YZ, Wang YY. Human cytomegalovirus protein UL94 targets MITA to evade the antiviral immune response[J]. J Virol, 2020, 94:e00022-20. [12] Fu YZ, Su S, Gao YQ, Wang PP, Huang ZF, Hu MM, Luo WW, Li S, Luo MH, Wang YY, Shu HB. Human cytomegalovirus tegument protein UL82 inhibits STING-mediated signaling to evade antiviral immunity[J]. Cell Host Microbe, 2017, 21:231-243. [13] Krishna BA, Miller WE, O'Connor CM. US28:HCMV's Swiss Army Knife[J]. Viruses, 2018, 10:445. [14] De Groof TWM, Elder EG, Lim EY, Heukers R, Bergkamp ND, Groves IJ, Wills M, Sinclair JH, Smit MJ. Targeting the latent human cytomegalovirus reservoir for T-cell-mediated killing with virus-specific nanobodies[J]. Nat Commun, 2021, 12:4436. [15] Rotondo JC, Mazzoni E, Bononi I, Tognon M, Martini F. Association between simian virus 40 and human tumors[J]. Front Oncol, 2019, 9:670. [16] Farias KPRA, Moreli ML, Floriano VG, da Costa VG. Evidence based on a meta-analysis of human cytomegalovirus infection in glioma[J]. Arch Virol, 2019, 164:1249-1257. [17] Nauclér CS, Geisler J, Vetvik K. The emerging role of human cytomegalovirus infection in human carcinogenesis:a review of current evidence and potential therapeutic implications[J]. Oncotarget, 2019, 10:4333-4347. [18] Ferreira DA, Tayyar Y, Idris A, McMillan NAJ. A "hit-and-run" affair:a possible link for cancer progression in virally driven cancers[J]. Biochim Biophys Acta Rev Cancer, 2021, 1875:188476. [19] Zapatka M, Borozan I, Brewer DS, Iskar M, Grundhoff A, Alawi M, Desai N, Sültmann H, Moch H, Cooper CS, Eils R, Ferretti V, Lichter P; PCAWG Pathogens, PCAWG Consortium. The landscape of viral associations in human cancers[J]. Nat Genet, 2020, 52:320-330. [20] Ružić T, Juranić Lisnić V, Mahmutefendić Lučin H, Lenac Roviš T, Železnjak J, Cokarić Brdovčak M, Vrbanović A, Oreb D, Kveštak D, Gotovac Jerčić K, Borovečki F, Lučin P, Adler B, Jonjić S, Lisnić B. Characterization of M116.1p, a murine cytomegalovirus protein required for efficient infection of mononuclear phagocytes[J]. J Virol, 2022, 96:e0087621. [21] Krenzlin H, Behera P, Lorenz V, Passaro C, Zdioruk M, Nowicki MO, Grauwet K, Zhang H, Skubal M, Ito H, Zane R, Gutknecht M, Griessl MB, Ricklefs F, Ding L, Peled S, Rooj A, James CD, Cobbs CS, Cook CH, Chiocca EA, Lawler SE. Cytomegalovirus promotes murine glioblastoma growth via pericyte recruitment and angiogenesis[J]. J Clin Invest, 2019, 129:1671-1683. [22] Roark HK, Jenks JA, Permar SR, Schleiss MR. Animal models of congenital cytomegalovirus transmission:implications for vaccine development[J]. J Infect Dis, 2020, 221(Suppl 1):S60-73. [23] Cobbs C. Cytomegalovirus is a tumor-associated virus:armed and dangerous[J]. Curr Opin Virol, 2019, 39:49-59. [24] Daly CA, Smit MJ, Plouffe B. The constitutive activity of the viral-encoded G protein-coupled receptor US28 supports a complex signalling network contributing to cancer development[J]. Biochem Soc Trans, 2020, 48:1493-1504. [25] Vischer HF, Siderius M, Leurs R, Smit MJ. Herpesvirus-encoded GPCRs:neglected players in inflammatory and proliferative diseases[J]? Nat Rev Drug Discov, 2014, 13:123-139. [26] de Wit RH, Mujić-Delić A, van Senten JR, Fraile-Ramos A, Siderius M, Smit MJ. Human cytomegalovirus encoded chemokine receptor US28 activates the HIF-1α/PKM2 axis in glioblastoma cells[J]. Oncotarget, 2016, 7:67966-67985. [27] Wu SE, Miller WE. The HCMV US28 vGPCR induces potent Gαq/PLC-β signaling in monocytes leading to increased adhesion to endothelial cells[J]. Virology, 2016, 497:233-243. [28] Crawford LB, Caposio P, Kreklywich C, Pham AH, Hancock MH, Jones TA, Smith PP, Yurochko AD, Nelson JA, Streblow DN. Human cytomegalovirus US28 ligand binding activity is required for latency in CD34+ hematopoietic progenitor cells and humanized NSG mice[J]. mBio, 2019, 10:e01889-19. [29] Wightman SM, Alban TJ, Chen X, Lathia JD, Wang Y, Stark GR. Bazedoxifene inhibits sustained STAT3 activation and increases survival in GBM[J]. Transl Oncol, 2021, 14:101192. [30] Cobbs CS. Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis[J]. Herpesviridae, 2011, 2:10. [31] Rivers TM. Viruses and Koch's postulates[J]. J Bacteriol, 1937, 33:1-12. [32] Dey M, Ahmed AU, Lesniak MS. Cytomegalovirus and glioma:putting the cart before the horse[J]. J Neurol Neurosurg Psychiatry, 2015, 86:191-199. [33] Hosainzadegan H, Khalilov R, Gholizadeh P. The necessity to revise Koch's postulates and its application to infectious and non-infectious diseases:a mini-review[J]. Eur J Clin Microbiol Infect Dis, 2020, 39:215-218. [34] Smibert OC, Allison CC, Doerflinger M, Pellegrini M, Rischin D, Thai A, Slavin MA, Kotton CN. Pseudotumor presentation of CMV disease:diagnostic dilemma and association with immunomodulating therapy[J]. Transpl Infect Dis, 2021, 23:e13531. [35] Lan Q, Chen Y, Dai C, Li S, Fei X, Dong J, Shen Y, Dai X, Lu Z, Liu B, Wang Q, Wang H, Zhou Z, Ji X, Wang Z, Huang Q. Novel enhanced GFP-positive congenic inbred strain establishment and application of tumor-bearing nude mouse model[J]. Cancer Sci, 2020, 111:3626-3638. [36] Wang A, Dai X, Cui B, Fei X, Chen Y, Zhang J, Zhang Q, Zhao Y, Wang Z, Chen H, Lan Q, Dong J, Huang Q. Experimental research of host macrophage canceration induced by glioma stem progenitor cells[J]. Mol Med Rep, 2015, 11:2435-2442. |